A Retrospective Cohort Study of Acute Pancreatitis in Relation to Use of Byetta (Exenatide) and Other Antidiabetic Agents.
Phase of Trial: Phase IV
Latest Information Update: 17 Jul 2014
At a glance
- Drugs Exenatide (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Amylin Pharmaceuticals; AstraZeneca
- 05 Oct 2010 Additional lead trial center identified as reported by ClinicalTrials.gov.
- 26 Jun 2010 Results reported at American Diabetes Association (ADA) meeting, according to an Amylin media release.
- 04 Mar 2010 New trial record